CIM
ZYME icon

Contravisory Investment Management’s Zymeworks ZYME Stock Holding History

Contravisory Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,250
Closed -$46K – 286
2020
Q2 		$46K Buy
+1,250
New +$46K 0.02% 201

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Contravisory Investment Management's ZYME Position: Q3 2020 in Review

Contravisory Investment Management sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 1,250 shares — an estimated $46K sold.

Contravisory Investment Management first reported a position in ZYME in Q2 2020 and held it in 1 quarter. The position peaked at $46K in Q2 2020. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

  • Contravisory Investment Management reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
  • Contravisory Investment Management sold 1,250 Zymeworks shares in Q3 2020, an estimated $46K.
  • Contravisory Investment Management first reported a position in Zymeworks in Q2 2020 and held it in 1 quarter.
  • Contravisory Investment Management's Zymeworks position peaked at $46K in Q2 2020.
  • 127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Contravisory Investment Management's 13F filing for Q3 2020, filed 8 Oct 2020.